As one of the top pediatric treatment and research programs in the country, our Bone Marrow Failure Program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center provides advanced treatments, quality-assurance diagnostic services, and DNA mutation identification through a certified laboratory for children with bone marrow failure and related conditions. We treat a wide range of disorders, including aplastic anemia, Fanconi anemia, severe congenital neutropenia, Diamond-Blackfan anemia, and thrombocytopenia absent radii, among other conditions.
Dana-Farber/Boston Children’s is an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. We offer, in one specialized program, the full spectrum of services that are needed for diagnosis, treatment and ongoing care of even the rarest and hard-to-treat conditions.
Patients in the Bone Marrow Failure Program receive care from a team of hematologists and bone marrow failure specialists, who are also active researchers. In addition, our team includes medical specialists, such as cardiologists, geneticists, and endocrinologists, who are familiar with pediatric bone marrow failure.
With a focus on translating scientific discoveries to the patient’s bedside, our physicians and scientists are developing new drugs to treat bone marrow failure and working on better understanding of the genetic and molecular aspects of bone marrow failure syndromes.
Learn more about our Bone Marrow Failure Program on the Dana-Farber/Boston Children’s website.